IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
206.63
+2.29 (1.12%)
At close: Oct 3, 2025, 4:00 PM EDT
208.08
+1.45 (0.70%)
Pre-market: Oct 6, 2025, 9:02 AM EDT
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $35.13 billion as of October 6, 2025. Its market cap has decreased by -20.60% in one year.
Market Cap
35.13B
Enterprise Value
48.68B
1-Year Change
-20.60%
Ranking
Category
Stock Price
$206.63
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $35.13B, an increase of 543.62%. That is a compound annual growth rate of 16.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 35.13B | -1.51% |
Dec 31, 2024 | 35.67B | -15.54% |
Dec 29, 2023 | 42.23B | 10.96% |
Dec 30, 2022 | 38.06B | -29.39% |
Dec 31, 2021 | 53.90B | 56.91% |
Dec 31, 2020 | 34.35B | 14.58% |
Dec 31, 2019 | 29.98B | 27.57% |
Dec 31, 2018 | 23.50B | 13.60% |
Dec 29, 2017 | 20.69B | 10.50% |
Dec 30, 2016 | 18.72B | 121.52% |
Dec 31, 2015 | 8.45B | 12.33% |
Dec 31, 2014 | 7.52B | 25.93% |
Dec 31, 2013 | 5.97B | 9.47% |
May 9, 2013 | 5.46B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 753.98B |
Johnson & Johnson | 454.31B |
AbbVie | 413.22B |
UnitedHealth Group | 326.22B |
Novo Nordisk | 264.73B |
AstraZeneca | 264.35B |
Novartis AG | 256.18B |
Abbott Laboratories | 234.25B |